Hülse, Patricia http://orcid.org/0000-0003-2008-3942
Reitemeyer, Emanuel
Rübsam, Anne http://orcid.org/0000-0001-6202-1710
Pleyer, Uwe http://orcid.org/0000-0002-5569-1473
Maier, Anna-Karina B. http://orcid.org/0000-0002-8095-0254
Funding for this research was provided by:
Charité - Universitätsmedizin Berlin
Article History
Received: 13 March 2023
Revised: 15 June 2023
Accepted: 11 July 2023
First Online: 22 July 2023
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the Ethics Committee of the Charité–Universitätsmedizin Berlin (EA4/168/17) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Clinical trial registration was performed (website: https://www.drks.de/drks_web/, trial number: DRKS00028266).
: Informed consent was obtained from all individual participants included in the study.
: P.H. and E.R. report no financial interests. AR received speaking honoraria from Bayer Healthcare, Roche, and Novartis and served as a consultant for Novartis. AR receives research support from Deutsche Forschungsgemeinschaft (DFG) (RU 2020/3-1). A.-K. M. has served as a consultant for Allergan and Novartis. U.P. has served as a principal investigator or consultant for AbbVie, Alcon, Allergan, Alimera, Bayer, Dompé, Novartis, Santen, Shire, and Thea.